Navigation Links
Micromet Reports Interim Data from Phase 1 Study of BiTE Antibody MT110 for the Treatment of Solid Tumors
Date:9/21/2009

be discovered upon further analysis of preclinical or clinical trial data, the risk that we or our collaborators will not obtain approval to market our product candidates, the risks associated with reliance on outside financing to meet capital requirements, and the risks associated with reliance on collaborators, including Bayer Schering Pharma, MedImmune, Merck Serono, TRACON and Nycomed, for the funding or conduct of further development and commercialization activities relating to our product candidates. These factors and others are more fully discussed in Micromet's Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2009, filed with the SEC on August 6, 2009, as well as other filings by the company with the SEC.


'/>"/>
SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
2. Micromet to Present at the Sachs Associates 7th Annual Biotech in Europe Investor Forum
3. Micromet Data Presented at the International AACR-NCI-EORTC Conference Support the Development of Adecatumumab (MT201) in Earlier Stage Cancer Disease Settings
4. Micromet is Presenting Four Posters on BiTE(R) Antibodies at the International AACR-NCI-EORTC Conference
5. Micromet to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on November 7, 2007
6. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
7. Micromet to Present at the 2007 RBC Capital Markets Healthcare Conference on December 12, 2007
8. Micromet to Present at Two Upcoming Investor Conferences
9. Micromet to Present at the Susquehanna Financial Groups SIGnificant Investment Options Conference on March 4, 2008
10. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
11. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/3/2015)... (PRWEB) June 03, 2015 From smart ... an important part in enabling success in dealing with ... and technology leaders helped bring focus to the role ... the Photonics21 annual meeting last week in ... the event, held 28 and 29 May at the ...
(Date:6/2/2015)... TORONTO , June 2, 2015 /PRNewswire/ - Aptose ... clinical-stage company developing new therapeutics that target the underlying ... and Drug Administration (FDA) has granted the company orphan ... myeloid leukemia (AML). APTO-253, a first-in-class inducer of the ... a Phase Ib clinical trial in patients with AML, ...
(Date:6/2/2015)... , Jun. 02, 2015 Tauriga Sciences, ... diversified life sciences company with interests in the ... synthetic biology platform technology, today announced that it ... Co-Investment, LLC ("Typenex") in exchange for a one-time ... 2015, the Company and Typenex entered into a ...
(Date:6/2/2015)... 2, 2015 Meet ARGUS, The ... Scan & Read People. Analyze emotions and predict actions. ... including the very first Responsive-RPG: "The Eye: Genesis". ... , , , , https://www.youtube.com/watch?v=B1ZEtAZ2Yf8 ... affect your inner feelings - and those of others. ...
Breaking Biology Technology:Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 2Photonics21 Annual Meeting Focuses on Solutions for ‘Societal Challenges’ 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 2Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 3Aptose Biosciences Granted Orphan Drug Designation by the U.S. FDA for APTO-253 in Acute Myeloid Leukemia 4Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 2Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 3Tauriga Sciences, Inc. Extinguishes All Further Obligations to Typenex Co-Investment LLC with One-Time Cash Payment of $230,000 USD 4ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 2ARGUS - The World's First Inner Emotion Scanner Launches on KickStarter 3
... Reflects Emphasis on Drug Development and Recent ... Private ... Inc. (Nasdaq: LXRX ) announced several changes to the,composition ... development and the completion of a major strategic financing,with Invus, ...
... N.C., Sept. 25 DrScore.com, a nationwide,service ... their physicians,feedback online, announced today that it ... provides medical practices with free,practice-branded Web sites ... the terms of the partnership between DrScore ...
... Israel, Sept. 25 ,Monsanto Company (NYSE: MON ... collaboration to improve nitrogen use efficiency in corn, ... exclusive rights to,a number of genes discovered by ... of nitrogen. Monsanto will work to evaluate the ...
Cached Biology Technology:Lexicon Appoints Judith Swain, M.D. to Board of Directors 2Lexicon Appoints Judith Swain, M.D. to Board of Directors 3Lexicon Appoints Judith Swain, M.D. to Board of Directors 4DrScore.com Partners With Vivacare For Patient Education And Feedback 2Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 2Monsanto and Evogene Collaborate on Nitrogen Use Efficiency Research 3
(Date:5/6/2015)... , May 6, 2015 LifeBEAM, a ... established helmet producer, announced today that they will expand ... the world,s first bio-sensing cycling helmet and the first ... in two new colors in order to give cyclists ... product. In addition, LifeBEAM and Lazer announced their plan ...
(Date:4/21/2015)... 2015 High crime rate, ... boosting access control systems market in Saudi ... recently published report by TechSci Research " Saudi Arabia Access ... control systems market in Saudi Arabia ... access control systems market in the Kingdom is growing ...
(Date:4/14/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... growing mobile commerce market, announces that its Wocket® smart ... Design Awards under the category  ,Product Design – Technology,. ... are part of a global multi-disciplinary awards program. The ... marketplace, industry and judging panel. Winners will be announced ...
Breaking Biology News(10 mins):LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 2Saudi Arabia Access Control Systems Market to Touch USD1.2 Billion by 2020 Says TechSci Research 3NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 2NXT-ID's Wocket Smart Wallet Nominated for 2015 New York Design Awards in 'Product Design- Technology' 3
... Chemists say they have identified a gene that appears to ... diabetes, also known as insulin-dependent or juvenile diabetes, a disease ... is on the rise worldwide. They described their findings, which ... gene therapy, today at the 229th national meeting of the ...
... International HapMap Consortium, boosted by an additional $3.3 million ... even more powerful map of human genetic variation than ... genes related to common diseases, such as asthma, cancer, ... launched in October 2002, the consortium set September 2005 ...
... (MRS) for the first time to examine energy production ... have found substantial energy deficits in failing hearts. , ... the Proceedings of the National Academy of Sciences, confirm ... failure, and suggest new treatments designed to reduce energy ...
Cached Biology News:Towards precise classification of cancers based on robust gene functional expression profiles 2Towards precise classification of cancers based on robust gene functional expression profiles 3International HapMap consortium expands mapping effort 2International HapMap consortium expands mapping effort 3International HapMap consortium expands mapping effort 4Special Imaging Study Shows Failing Hearts Are 'Energy Starved' 2
...
... series offers versatile liquid handling platforms and ... wide variety of life science applications.The Freedom ... sizes (75, 100, 150 and 200 cm), ... platform that will advance with their application ...
... utilizes utilizies CTI Molecular Imaging's proprietary ... resolution, sensitivty, and a large imaging ... flexibility to image multiple mice or ... is a dedicated small animal PET ...
... Diluent (MOPS Buffered) has been developed specifically ... in solution. HRP Stabilizer prevents the ... conformation of the antibody or protein antigen ... filtered at 0.2 microns., ,Contents: Aqueous, ...
Biology Products: